Condition

Malignant Neoplasms, Brain (2)

Brain Neoplasms (1)

Brain Tumors (1)

Low-Grade Gliomas (1)

Soft Tissue Neoplasms (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

BioNumerik Pharmaceuticals, Inc. (1)

Children's Hospital Los Angeles (1)

Collaborator

Crown Bioscience (1)

Dana-Farber Cancer Institute (1)

Intervention

karenitecin (bnp1350) (1)

mek162 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

malignant neoplasms, brain

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

Active, not recruiting

Low-Grade Gliomas
+2 more

MEK162

Birmingham, Alabama
+14 more

Jan 25, 2023

Brain Tumors, Malignant Tumors, Brain, Brain Tumors Trial in Durham (Karenitecin (BNP1350))

Completed

Brain Neoplasms
+2 more

Karenitecin (BNP1350)

Durham, North Carolina

For Information call 210-614-1701 for a site near you

Mar 10, 2020